Copertina

JAK2‐mutated abnormal megakaryocytic proliferation without thrombocytosis: a diagnostic challenge

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Triantafyllia Koletsa, Kassiani Boulogeorgou, Sofia Chatzileontiadou, Amalia Fola, Maria Florou, Maria Papaioannou, Evdoxia Hatjiharissi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Histopathology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pathological features, differential diagnosis, prognosis, and diagnostic challenges in the classification of penile squamous neoplasia
di: Ingrid Rodriguez, et al.
Pubblicazione: (2025)

Myxoid “pauci‐hemosiderotic” fibrolipomatous tumour: a diagnostic challenge
di: Paige O'Connor, et al.
Pubblicazione: (2024)

Glutamine fructose 6‐phosphate transaminase‐2 as a marker of mesothelial proliferations
di: Andrew Churg, et al.
Pubblicazione: (2026)

Response to: ‘Glutamine–fructose‐6‐phosphate transaminase 2 as a marker of mesothelial proliferation’
di: Jia Wei, et al.
Pubblicazione: (2026)

Malignant vascular neoplasms of the distal female genital tract: a series of 19 cases emphasizing unusual features and diagnostic challenges
di: Aarti E Sharma, et al.
Pubblicazione: (2026)

Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
di: Ying‐Hsia Chu, et al.
Pubblicazione: (2024)

CD71 expression in Rosai–Dorfman disease: a useful adjunct marker in the differential diagnosis of histiocytic proliferations
di: Nurfiza N Ladak, et al.
Pubblicazione: (2026)

Role of artificial intelligence in haematolymphoid diagnostics
di: Charlotte Syrykh, et al.
Pubblicazione: (2024)

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) and mature plasmacytoid dendritic cell proliferation (MPDCP): the same cell of origin from a clonal haematopoiesis of indeterminate potential (CHIP)?
di: Margherita Vannucchi, et al.
Pubblicazione: (2025)

Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma
di: Alexander J Neil, et al.
Pubblicazione: (2025)

Integrated diagnostics, complex biomarkers, and a new frontier for tissue pathology
di: Manuel Salto‐Tellez, et al.
Pubblicazione: (2024)

Pros and cons of artificial intelligence implementation in diagnostic pathology
di: Paul J van Diest, et al.
Pubblicazione: (2024)

Transforming diagnostics: The implementation of digital pathology in clinical laboratories
di: Christine Bruce, et al.
Pubblicazione: (2024)

Vascular, adipose tissue, and/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios
di: Ankur R Sangoi, et al.
Pubblicazione: (2024)

PTEN frameshift mutation in two atypical meningiomas: case reports and review of the literature
di: Neşe Yeldir, et al.
Pubblicazione: (2026)

Ossifying fibromyxoid tumours with lipomatous and cartilaginous differentiation: A diagnostic pitfall
di: Natálie Klubíčková, et al.
Pubblicazione: (2024)

Immunophenotypic spectrum and mutational landscape of EBV ‐positive inflammatory follicular dendritic cell sarcoma
di: Jian‐Chao Wang, et al.
Pubblicazione: (2026)

TERT promoter mutations are useful to distinguish phyllodes tumours with a fibroadenoma‐like morphology from cellular fibroadenomas
di: Alex Fortun, et al.
Pubblicazione: (2025)

DCIS‐like invasive carcinoma of the breast with tumour‐associated microvasculature mimicking myoepithelium: a diagnostic pitfall
di: Taylor Salisbury, et al.
Pubblicazione: (2025)

Perceived image quality and diagnostic sufficiency of whole slide imaging scanners: a pathologist‐centred evaluation
di: Jonas Bäcker, et al.
Pubblicazione: (2026)

Recent advancements in biomarkers and molecular diagnostics in hormonal receptor‐positive breast cancer
di: Yihong Wang, et al.
Pubblicazione: (2024)

Genetic and immunohistochemical studies identify recurrent ACTB mutations and PTEN alterations in tubular adenomas of the breast
di: Hnin Ingyin, et al.
Pubblicazione: (2025)

TERT promoter–mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification
di: Seung Eun Lee, et al.
Pubblicazione: (2026)

Primary cutaneous sarcomatoid squamous cell carcinoma: a comprehensive clinicopathological and immunohistochemical study focusing on diagnostic pitfalls
di: Jose A Plaza, et al.
Pubblicazione: (2025)

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate
di: Jianping Zhao, et al.
Pubblicazione: (2026)

NMD ‐insensitive CDH1 mutation as a mechanism for retained E‐cadherin protein expression in lobular carcinoma in situ ( LCIS )
di: Matthias Christgen, et al.
Pubblicazione: (2025)

Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience
di: Irene Moysset, et al.
Pubblicazione: (2024)

Genomic analysis of primary epithelial neoplasms of the seminal vesicle identifies a subset of mucinous cystic tumours driven by KRAS mutations
di: Katrina Collins, et al.
Pubblicazione: (2024)

Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges
di: Natthawadee Laokulrath, et al.
Pubblicazione: (2024)

Morphological, immunohistochemical and molecular analysis of follicular dendritic cell sarcomas: L1CAM as a new diagnostic marker
di: Selina Schelbert, et al.
Pubblicazione: (2025)

Correlation between CTNNB1 mutation status and tumour phenotype in hepatitis B virus‐related hepatocellular carcinoma
di: Yoon Jung Hwang, et al.
Pubblicazione: (2024)

Despite simplified diagnostic criteria, intraobserver and interobserver variability remain in the interpretation of colorectal serrated polyps
di: Adam L. Booth, et al.
Pubblicazione: (2026)

EBV ‐associated smooth muscle tumour: a clinicopathological and genetic study of nine cases revealing heterogeneous immune statuses and novel pathogenic mutations
di: Wenyi Jing, et al.
Pubblicazione: (2025)

Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers
di: Pierre Sohier, et al.
Pubblicazione: (2025)

The role of rapid IHC in elevating STAS diagnostic accuracy during intraoperative frozen section for lung adenocarcinoma
di: Jialin Lu, et al.
Pubblicazione: (2026)

Diandric triploid partial mole versus digynic nonmolar triploidy: is morphological assessment sufficient for the diagnostic distinction?
di: Agnes Nagy, et al.
Pubblicazione: (2024)

Dedicated diagnostic approaches for mature B‐cell non‐Hodgkin lymphomas occurring in children, adolescents, and young adults
di: Ana C Xavier, et al.
Pubblicazione: (2024)

Understanding cholangiocarcinoma: molecular landscape, pathological classification, and challenges in biopsy diagnosis
di: Yoh Zen
Pubblicazione: (2026)

Pathologists' nightmare or challenge accepted? Soft tissue tumours of the genitourinary tract
di: Minh Anh Nguyen, et al.
Pubblicazione: (2025)

Duodenal neuroendocrine tumours masquerading as peptic duodenitis, crushed lymphoid aggregates and prominent Brunner glands: some diagnostic pitfalls
di: Lena Hasson, et al.
Pubblicazione: (2025)